Meeder Asset Management Inc Infinity Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$0.88 - $1.29 $3,069 - $4,499	-3,488 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$1.03 - $1.75 $1,279 - $2,173	1,242 Added 55.3%	3,488 $4,000
Q1 2019 Apr 16, 2019	BUY	$1.18 - $1.91 $572 - $926	485 Added 27.54%	2,246 $4,000
Q4 2018 Jan 17, 2019	SELL	$1.01 - $2.78 $790 - $2,176	-783 Reduced 30.78%	1,761 $2,000
Q3 2018 Nov 02, 2018	BUY	$1.72 - $2.71 $1,764 - $2,780	1,026 Added 67.59%	2,544 $0
Q2 2018 Jul 24, 2018	BUY	$1.72 - $2.26 $428 - $562	249 Added 19.62%	1,518 $0
Q1 2018 May 03, 2018	BUY	$1.8 - $2.74 $495 - $753	275 Added 27.67%	1,269 $3,000
Q4 2017 Feb 02, 2018	SELL	$1.22 - $3.73 $2,005 - $6,132	-1,644 Reduced 62.32%	994 $2,000
Q3 2017 Oct 20, 2017	BUY	$0.94 - $1.35 $2,479 - $3,561	2,638	2,638 $4,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.